drugset / Trial / NCT03498248
Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to analyze the clinical factors associated with the effect of Granulocyte-Colony Stimulating Factor (G-CSF).
Timeline
- Start
- 2018-02-19
- Primary completion
- 2018-08-31
- Completion
- 2019-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenograstim | Protein / enzyme biologic | 250 ug | Subcutaneous |